APA

Mazurov A. V., Pevzner D. V., Antonova O. A., Byzova T. V., Khaspekova S. G., Semenov A. V., Vlasik T. N., Samko A. N., Staroverov I. I. & Ruda M. Y. (20030609). Safety, inhibition of platelet aggregation and pharmacokinetics of Fab'2 fragments of the anti-glycoprotein IIb-IIIa monoclonal antibody FRaMon in high-risk coronary angioplasty. : Platelets.

Chicago

Mazurov A V, Pevzner D V, Antonova O A, Byzova T V, Khaspekova S G, Semenov A V, Vlasik T N, Samko A N, Staroverov I I and Ruda M Ya. 20030609. Safety, inhibition of platelet aggregation and pharmacokinetics of Fab'2 fragments of the anti-glycoprotein IIb-IIIa monoclonal antibody FRaMon in high-risk coronary angioplasty. : Platelets.

Harvard

Mazurov A. V., Pevzner D. V., Antonova O. A., Byzova T. V., Khaspekova S. G., Semenov A. V., Vlasik T. N., Samko A. N., Staroverov I. I. and Ruda M. Y. (20030609). Safety, inhibition of platelet aggregation and pharmacokinetics of Fab'2 fragments of the anti-glycoprotein IIb-IIIa monoclonal antibody FRaMon in high-risk coronary angioplasty. : Platelets.

MLA

Mazurov A V, Pevzner D V, Antonova O A, Byzova T V, Khaspekova S G, Semenov A V, Vlasik T N, Samko A N, Staroverov I I and Ruda M Ya. Safety, inhibition of platelet aggregation and pharmacokinetics of Fab'2 fragments of the anti-glycoprotein IIb-IIIa monoclonal antibody FRaMon in high-risk coronary angioplasty. : Platelets. 20030609.